Patent details
EP3009128 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB
Basic Information
- Publication number:
- EP3009128
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP151842820
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB
- French Title of Invention:
- COMPOSITIONS PHARMACEUTIQUES DE NILOTINIB
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND NILOTINIB
- SPC Number:
Dates
- Filing date:
- 25/09/2007
- Grant date:
- 05/07/2023
- EP Publication Date:
- 20/04/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/07/2023
- EP B1 Publication Date:
- 05/07/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 25/09/2024
- Expiration date:
- 25/09/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/06/2023
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
- Name:
- BRUNEAU, Nathalie
- Address:
- France (FR)
Priority
- Priority Number:
- 06121371
- Priority Date:
- 27/09/2006
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 9/16; A61K 31/506; A61P 35/00; A61P 35/02; A61P 43/00;
Publication
European Patent Bulletin
- Issue number:
- 202327
- Publication date:
- 05/07/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 14/09/2023
- Last Annual Fee Paid Number:
- 17
- Last Annual Fee Paid Amount:
- 246 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|